Spots Global Cancer Trial Database for A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Official Title: A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Study ID: NCT01485835
Conditions
Study Description
Brief Summary: The purpose of this study is to find out what effects, good and/or bad, that ganetespib and bortezomib has on you and your cancer. The investigators will determine the side effects of different dose levels of ganetespib when given alone and the effect it has on your cancer alone. The investigators will also determine the side effects of ganetespib at different dose levels when given in combination with bortezomib and the effect the combination has on your cancer. The study will measure levels of the drug in your blood and bone marrow as well. Bortezomib is a proteasome inhibitor that is approved by the US Food and Drug Administration (FDA) that is used for the treatment of multiple myeloma. The brand name for bortezomib is Velcade®. Ganetespib is considered "investigational" because it has not received approval from the Food and Drug Administration for general use, although it has been previously tested in humans.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Colorado Blood Cancer Institute, Denver, Colorado, United States
Emory University Hospital Midtown, Atlanta, Georgia, United States
Emory University Winship Cancer Institute, Atlanta, Georgia, United States
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
Siteman Cancer Center at Washington University, Saint Louis, Missouri, United States
Levine Cancer Institute, Charlotte, North Carolina, United States
The Center for Cancer and Blood Disorders, Fort Worth, Texas, United States
Virginia Cancer Specialists, Fairfax, Virginia, United States
Contact Details
Name: Sagar Lonial, MD
Affiliation: Emory University Winship Cancer Institute
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
